CENTER FOR PUBLIC HEALTH KINETICS Contact Number, Address Details

Published date: October 1, 2022
Unique Id of VO/NGO DL/2018/0197911

CENTER FOR PUBLIC HEALTH KINETICS Registration Details

Registered With Sub-Registrar
Type of NGO Trust (Non-Government)
Registration No 5842
Copy of Registration Certificate Available
Copy of Pan Card Available
Act name THE INDIAN REGISTRATION ACT 1908 / INDIAN TRUST ACT 1882
City of Registration NEW DELHI
State of Registration DELHI
Date of Registration 09-11-2011

CENTER FOR PUBLIC HEALTH KINETICS Members

Name Designation Pan Aadhaar
DR SUNIL SAZAWAL Executive Trustee Available Available
WASEEM ALI Chief Finance officer Available Available
DR JITENDRA KUMAR Deputy Director Available Available

CENTER FOR PUBLIC HEALTH KINETICS Sector/ Key Issues

Key Issues Children,Health & Family Welfare,Nutrition,Scientific & Industrial Research,Any Other,Biotechnology,Children,Health & Family Welfare,Nutrition,Scientific & Industrial Research,Any Other
Operational Area-States DELHI, UTTAR PRADESH
Operational Area-District DELHI->East, New Delhi, South, UTTAR PRADESH->Meerut

CENTER FOR PUBLIC HEALTH KINETICS FCRA details

FCRA Available FCRA Registration no.
Not Available Not Available

CENTER FOR PUBLIC HEALTH KINETICS Details of Achievements

1. Effect of Zinc Supplementation on acute diarrhoea, persistent diarrhoea and dysentery of young children led to revision of program recommendations to include zinc as a treatment for diarrhoea by WHO, UNICEF, IAP

CENTER FOR PUBLIC HEALTH KINETICS Source of Funds

Department Name Source Finacial Year Amount Sanctioned Purpose
World Health Organization Overseas 2016-2017 69684258 Project Started on 21/06/2016. During FY 16-17 the support structure was setup. Amount sanctioned is for entire Study Duration. Project Objectives: 1. To Compare rates of all-Cause mortality 2. To compare the average change in linear growth in the 90 days following an episode of high risk diarrhoea without dysentery among children 2 to 23 months of age living in low resource settings who are randomized to receive a 3-day course of azithromycin , a 3-day course of ciprofloxacin or placebo.
World Health Organization Overseas 2016-2017 30168000 PROJECT OBJECTIVES: 1. To evaluate the non-inferiority of lower Zinc doses (10 mg/day and 5 mg/day) versus standard Zinc Dose (20 mg/day) regarding diarrhoea (duration of symptoms, and risk of diarrhoea > 5 days) 2. To evaluate the safety of lower dose versus standard dose Zinc regarding vomiting and other adverse events, and 3. To Evaluate the acceptability of lower doses versus standard dose Zinc using an acceptability scale
World Health Organization Overseas 2015-2016 11656224 The AMANHI STUDY, Using on-going newborn intervention trials to obtain additional data critical to maternal, fetal and newborn in a harmonized way.
Johns Hopkins Bloomberg School of Public Health Overseas 2014-2015 10924338 Efficacy of High Zinc-Biofortified Wheat Consumption in Improvement of Micronutrient Status and Prevention of Morbidity among Pre-School Children (aged 4-6 Years) and Women of Child Bearing Age, A double Masked, Randomized, Controlled Trial.
World Health Organization Overseas 2017-2018 22459385 Project Objectives: 1. To Compare rates of all-Cause mortality 2. To compare the average change in linear growth in the 90 days following an episode of high risk diarrhoea without dysentery among children 2 to 23 months of age living in low resource settings who are randomized to receive a 3-day course of azithromycin , a 3-day course of ciprofloxacin or placebo.
World Health Organization Overseas 2020-2021 14187047 Project Objectives: 1. To Compare rates of all-Cause mortality 2. To compare the average change in linear growth in the 90 days following an episode of high risk diarrhoea without dysentery among children 2 to 23 months of age living in low resource settings who are randomized to receive a 3-day course of azithromycin , a 3-day course of ciprofloxacin or placebo.
World Health Organization Overseas 2017-2018 21389573 PROJECT OBJECTIVES: 1. To evaluate the non-inferiority of lower Zinc doses (10 mg/day and 5 mg/day) versus standard Zinc Dose (20 mg/day) regarding diarrhoea (duration of symptoms, and risk of diarrhoea
World Health Organization Overseas 2018-2019 52828936 1. To Compare rates of all-Cause mortality 2. To compare the average change in linear growth in the 90 days following an episode of high risk diarrhoea without dysentery among children 2 to 23 months of age living in low resource settings who are randomized to receive a 3-day course of azithromycin , a 3-day course of ciprofloxacin or placebo.
World Health Organization Overseas 2018-2019 22146883 PROJECT OBJECTIVES: 1. To evaluate the non-inferiority of lower Zinc doses (10 mg/day and 5 mg/day) versus standard Zinc Dose (20 mg/day) regarding diarrhoea (duration of symptoms, and risk of diarrhoea
World Health Organization Overseas 2019-2020 55746372 1. To Compare rates of all-Cause mortality 2. To compare the average change in linear growth in the 90 days following an episode of high risk diarrhoea without dysentery among children 2 to 23 months of age living in low resource settings who are randomized to receive a 3-day course of azithromycin , a 3-day course of ciprofloxacin or placebo.
World Health Organization Overseas 2019-2020 Not Specified Leftover Funds Used from previous Year PROJECT OBJECTIVES: To evaluate the non-inferiority of lower Zinc doses (10 mg/day and 5 mg/day) versus standard Zinc Dose (20 mg/day) regarding diarrhoea (duration of symptoms, and risk of diarrhoea

CENTER FOR PUBLIC HEALTH KINETICS Contact Details

Address 214-A, BASEMENT, VINOBA PURI, LAJPAT NAGAR-II
City NEW DELHI
State DELHI
Telephone Not Available
Mobile No 9650471973
Website Url Not Available
E-mail waseemali@cphk.net.in

Related listings

Feedback / Rewiews

    Leave your comment (spam and offensive messages will be removed)